These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19620818)

  • 21. Management of patients with overt or resolved hepatitis B virus infection undergoing rituximab therapy.
    Viganò M; Mangia G; Lampertico P
    Expert Opin Biol Ther; 2014 Jul; 14(7):1019-31. PubMed ID: 24909454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactivation of Occult Hepatitis B Virus Infection 27 Months after the End of Chemotherapy Including Rituximab for Malignant Lymphoma.
    Muraishi J; Shibata M; Honma Y; Hiura M; Abe S; Harada M
    Intern Med; 2017; 56(15):1967-1971. PubMed ID: 28768965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Icteric hepatitis in a patient with non-Hodgkin's lymphoma treated by rituximab-based chemotherapy].
    Coppola N; Masiello A; Tonziello G; Macera M; Iodice V; Caprio N; Pasquale G
    Infez Med; 2010 Jun; 18(2):127-31. PubMed ID: 20610938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B virus reactivation in a case of non-Hodgkin's lymphoma treated with chemotherapy and rituximab: necessity of prophylaxis for hepatitis B virus reactivation in rituximab therapy.
    Tsutsumi Y; Kawamura T; Saitoh S; Yamada M; Obara S; Miura T; Kanamori H; Tanaka J; Asaka M; Imamura M; Masauzi N
    Leuk Lymphoma; 2004 Mar; 45(3):627-9. PubMed ID: 15160930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [B-cell lymphoma developing de novo hepatitis B after salvage therapies including rituximab through seroconversion of surface antibody].
    Ishihara T; Kanagawa M; Koyama J; Hasegawa K; Suzuki T; Hirayama Y; Terui T
    Rinsho Ketsueki; 2014 Nov; 55(11):2283-7. PubMed ID: 25501408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Reactivation of hepatitis B virus due to rituximab plus CHOP after preemptive lamivudine administration in a patient with diffuse large B-cell lymphoma].
    Ono K; Iyama S; Matsunaga T; Sato T; Sato Y; Okuda T; Takada K; Kawano Y; Hayashi T; Miyanishi K; Sagawa T; Kobune M; Takimoto R; Kato J; Niitsu Y
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1509-12. PubMed ID: 17876158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful use of entecavir for a severe case of reactivation of hepatitis B virus following polychemotherapy containing rituximab.
    Sanchez MJ; Buti M; Homs M; Palacios A; Rodriguez-Frias F; Esteban R
    J Hepatol; 2009 Dec; 51(6):1091-6. PubMed ID: 19836097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylaxis of hepatitis B reactivation using lamivudine in a patient receiving rituximab.
    Hamaki T; Kami M; Kusumi E; Ueyama J; Miyakoshi S; Morinaga S; Mutou Y
    Am J Hematol; 2001 Dec; 68(4):292-4. PubMed ID: 11754421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Entecavir as prophylaxis against hepatitis B virus reactivation following chemotherapy for lymphoma.
    Uchiyama M; Tamai Y; Ikeda T
    Int J Infect Dis; 2010 Mar; 14(3):e265-6. PubMed ID: 19665406
    [No Abstract]   [Full Text] [Related]  

  • 30. Prospective long-term study of hepatitis B virus reactivation in patients with hematologic malignancy.
    Tamori A; Hino M; Kawamura E; Fujii H; Uchida-Kobayashi S; Morikawa H; Nakamae H; Enomoto M; Murakami Y; Kawada N
    J Gastroenterol Hepatol; 2014 Sep; 29(9):1715-21. PubMed ID: 24730465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease.
    Chen FW; Coyle L; Jones BE; Pattullo V
    Liver Int; 2013 Sep; 33(8):1203-10. PubMed ID: 23522150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention of hepatitis B virus reactivation in B-cell lymphoma patients receiving chemotherapy with rituximab].
    Mimura N; Kojima H; Tsujimura H; Ise M; Sakai C; Fukai K; Yokosuka O; Kumagai K
    Rinsho Ketsueki; 2010 Mar; 51(3):213-5. PubMed ID: 20379117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations.
    Picardi M; Pane F; Quintarelli C; De Renzo A; Del Giudice A; De Divitiis B; Persico M; Ciancia R; Salvatore F; Rotoli B
    Haematologica; 2003 Nov; 88(11):1296-303. PubMed ID: 14607759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bendamustine in the treatment of non-Hodgkin's lymphoma: results and future perspectives.
    Rummel MJ; Mitrou PS; Hoelzer D
    Semin Oncol; 2002 Aug; 29(4 Suppl 13):27-32. PubMed ID: 12170430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Impending liver failure after chemoimmunotherapy-induced reactivation of hepatitis B - successful treatment with entecavir].
    Lock G; Helmich F; Bertram M
    Dtsch Med Wochenschr; 2012 Jun; 137(23):1248-50. PubMed ID: 22644491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful lamivudine therapy for post-chemotherapeutic fulminant hepatitis B in a hepatitis B virus carrier with non-Hodgkin's lymphoma: case report and review of the literature.
    Kawai Y; Ikegaya S; Hata M; Kawahito M; Imamura S; Yoshida A; Tsutani H; Ueda T
    Ann Hematol; 2001 Aug; 80(8):482-4. PubMed ID: 11563596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus infection prevalence and liver dysfunction in a cohort of B-cell non-Hodgkin's lymphoma patients treated with immunochemotherapy.
    Nosotti L; D'Andrea M; Pitidis A; Pimpinelli F; Dessanti ML; Pisani F; Vignally P; Petti MC
    Scand J Infect Dis; 2012 Jan; 44(1):70-3. PubMed ID: 21905952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy.
    Pei SN; Ma MC; Wang MC; Kuo CY; Rau KM; Su CY; Chen CH
    Ann Hematol; 2012 Jul; 91(7):1007-12. PubMed ID: 22273839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High rate of hepatitis B viral breakthrough in elderly non-Hodgkin lymphomas patients treated with Rituximab based chemotherapy.
    Castelli R; Ferraris L; Pantaleo G; Lambertenghi Deliliers G; Cicardi M
    Dig Liver Dis; 2016 Nov; 48(11):1394-1397. PubMed ID: 27590841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A malignant lymphoma (non-hodgkin lymphoma, follicular type) patient who achieved complete remission by radiochemotherapy].
    Tanaka T; Araki T; Kasuya G; Fujino T; Makita K
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1931-4. PubMed ID: 19920404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.